Dr. Martens (LON:DOCS) Trading Down 10.3% – Here’s Why

Dr. Martens plc (LON:DOCS)’s stock price dropped 10.3% on Tuesday . The stock traded as low as GBX 65 and last traded at GBX 67.88. Approximately 5,231,756 shares were traded during mid-day trading, an increase of 185% from the average daily volume of 1,832,502 shares. The stock had previously closed at GBX 75.65.

Analyst Ratings Changes

A number of research analysts have issued reports on DOCS shares. Berenberg Bank reissued a “buy” rating on shares of Dr. Martens in a research note on Tuesday. Peel Hunt restated a “buy” rating on shares of Dr. Martens in a research note on Thursday, November 20th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 6,000.

Dr. Martens Stock Performance

The stock’s fifty day moving average price is GBX 75.76 and its two-hundred day moving average price is GBX 83.16. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a market cap of £657.97 million, a P/E ratio of 40.04, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last announced its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Insiders Place Their Bets

In other Dr. Martens news, insider Robert Hanson purchased 96,000 shares of the company’s stock in a transaction dated Friday, December 5th. The stock was purchased at an average price of GBX 79 per share, with a total value of £75,840. Over the last 90 days, insiders have purchased 97,130 shares of company stock worth $7,673,816. Insiders own 2.79% of the company’s stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.